FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns a conjugate for drug delivery. The invention also concerns a pharmaceutical composition for eliminating a pathogen population in a host animal, containing said compound; as well as a method for eliminating the pathogen population in the host animal.
EFFECT: invention provides higher activity of the declared conjugate as compared with those known by the present technology.
3 cl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATES, CONTAINING HYDROPHILIC SPACERS OF LINKERS | 2008 |
|
RU2523909C2 |
| POLY-LIGAND MEDICINAL CONJUGATES AND USE THEREOF | 2016 |
|
RU2722449C2 |
| METHOD FOR TREATING CANCER BY TARGETING SUPPRESSOR CELLS OF MYELOID ORIGIN | 2017 |
|
RU2776899C2 |
| METHODS AND COMPOSITIONS FOR CAR-T-CELL THERAPY | 2017 |
|
RU2792653C2 |
| DRUG BILIGAND CONJUGATE AND USE THEREOF | 2020 |
|
RU2820346C2 |
| TARGETED CONJUGATES AND PARTICLES AND COMPOSITIONS THEREOF | 2015 |
|
RU2695220C2 |
| NEW OLIGONUCLEOTIDES CONJUGATES AND USE THEREOF | 2012 |
|
RU2599449C1 |
| TARGETING AMINOACID LIPIDS | 2013 |
|
RU2654210C2 |
| MONOMETHYLVALINE COMPOUNDS CAPABLE OF FORMING CONJUGATES WITH LIGANDS | 2004 |
|
RU2448117C2 |
| LIPOSOMAL COMPOSITIONS AND SOLID PERORAL MEDICINAL FORMS COMPRISING SUCH COMPOSITIONS | 2018 |
|
RU2751192C2 |
